US Stock MarketDetailed Quotes
PEN Penumbra
- 242.530
- -1.620-0.66%
Trading Nov 29 11:44 ET
9.31BMarket Cap278.77P/E (TTM)
246.610High242.530Low41.69KVolume241.770Open244.150Pre Close10.18MTurnover0.11%Turnover Ratio104.54P/E (Static)38.38MShares277.34052wk High8.43P/B8.98BFloat Cap148.00052wk Low--Dividend TTM37.04MShs Float348.670Historical High--Div YieldTTM1.67%Amplitude35.315Historical Low244.203Avg Price1Lot Size
About Penumbra Company
Penumbra, Inc. engages in the design, development, manufacture, and marketing of innovative medical devices. It offers neurovascular thrombectomy and embolization and access technologies, neurosurgical tools, Penumbra LANTERN Delivery Microcatheter, and Penumbra Occlusion Device (POD) system. The company was founded by Arani Bose and Adam Elsesser on June 21, 2004, and is headquartered in Alameda, CA.
Company Profile
SymbolPEN
Company NamePenumbra
Listing DateSep 18, 2015
Issue Price30.00
Founded2004
CEOMr. Adam Elsesser
MarketNYSE
Employees4200
Fiscal Year Ends12-31
AddressOne Penumbra Place
CityAlameda
ProvinceCalifornia
CountryUnited States of America
Zip Code94502
Phone1-510-748-3200
Websitehttp://www.penumbrainc.com
Company Executives
- Name
- Position
- Salary
- Adam Elsesser
- Chief Executive Officer, President and Chairman of the Board
- 601.62K
- Maggie Yuen
- Chief Financial Officer
- 666.04K
- Lambert Shiu
- Chief Accounting Officer
- 539.94K
- Johanna Roberts
- Executive Vice President, General Counsel and Secretary
- 661.89K
- Dr. Arani Bose, M.D.
- Director
- 233.99K
- Janet Leeds
- Independent Director
- 251.49K
- Harpreet Grewal
- Independent Director
- 241.49K
- Surbhi Sarna
- Independent Director
- 248.99K
- Don Kassing
- Presiding Independent Director
- 246.49K
- Bridget O'Rourke
- Independent Director
- 263.99K
- Thomas C. Wilder, III
- Independent Director
- 258.99K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data